🇺🇸 FDA
Patent

US 9382302

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 9382302 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58